Clinical Trial Update: Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) [Phase 1]

View source ↗

Summary

This document provides an update on a Phase 1 dose-escalation trial of cevostamab in participants with relapsed or refractory multiple myeloma. The study is spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Cevostamab (cevostamab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED